Chung J K, Lee Y J, Kim C, Choi S R, Kim M, Lee K, Jeong J M, Lee D S, Jang J J, Lee M C
Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Korea.
J Nucl Med. 1999 Feb;40(2):339-46.
[18F]Fluorodeoxyglucose ([18F]FDG), a glucose analogue, has been widely used for tumor imaging. To investigate the mechanisms related to [18F]FDG uptake by tumors, an experiment involving nude mice was performed.
Human colon cancer cell lines SNU-C2A, SNU-C4 and SNU-C5 were transplanted to nude mice. Using immunohistochemical staining and Western blot, the expression of glucose transporter (Glut) isoforms (Glut-1 through -5) in xenografted tumors was analyzed. For the analysis of messenger ribonucleic acid (mRNA) expression, reverse-transcription polymerase chain reaction and Northern blot were used and the enzyme activity of hexokinase in cancer tissues was measured by continuous spectrophotometric rate determination.
[18F]FDG uptake in SNU-C4 and SNU-C5 cells was higher than in normal colon cells. Among these cells and xenografted tumors, SNU-C5 showed the highest level of [18F]FDG uptake, followed by SNU-C4 and SNU-C2A. An immunostaining experiment showed intense staining of Glut-1 in SNU-C5 tumors but somewhat faint staining in SNU-C4. SNU-C5 tumors also showed positive staining with Glut-3, although this was not the case with SNU-C2A and SNU-C4. Western blot analysis showed the expression of Glut-1 and Glut-3 in all tumors. Experiments involving Northern blot analysis and reverse-transcription polymerase chain reaction confirmed the overexpression of Glut-1 mRNA in all tumors, with the highest level in SNU-C5. The level of Glut-3 mRNA was also elevated in SNU-C5 tumors but not in SNU-C2A and SNU-C4. The enzyme activity of hexokinase did not vary among different tumors.
Gluts, especially Glut-1, are responsible for [18F]FDG uptake in a nude mouse model of colon cancer rather than hexokinase activity. Increased numbers of glucose transporters at the plasma membrane of cancer cells is attributed to an increased level of transcripts of glucose transporter genes and may be a cause of increased [18F]FDG uptake, at least in colon cancer tumors.
[18F]氟脱氧葡萄糖([18F]FDG)是一种葡萄糖类似物,已广泛用于肿瘤成像。为了研究肿瘤摄取[18F]FDG的相关机制,进行了一项涉及裸鼠的实验。
将人结肠癌细胞系SNU - C2A、SNU - C4和SNU - C5移植到裸鼠体内。采用免疫组织化学染色和蛋白质印迹法,分析异种移植肿瘤中葡萄糖转运蛋白(Glut)同工型(Glut - 1至 - 5)的表达。为了分析信使核糖核酸(mRNA)表达,使用逆转录聚合酶链反应和Northern印迹法,并通过连续分光光度速率测定法测量癌组织中己糖激酶的酶活性。
SNU - C4和SNU - C5细胞对[18F]FDG的摄取高于正常结肠细胞。在这些细胞和异种移植肿瘤中,SNU - C5对[18F]FDG的摄取水平最高,其次是SNU - C4和SNU - C2A。免疫染色实验显示,SNU - C5肿瘤中Glut - 1染色强烈,而SNU - C4中染色稍淡。SNU - C5肿瘤中Glut - 3也呈阳性染色,而SNU - C2A和SNU - C4则不然。蛋白质印迹分析显示所有肿瘤中均有Glut - 1和Glut - 3表达。Northern印迹分析和逆转录聚合酶链反应实验证实,所有肿瘤中Glut - 1 mRNA均过表达,SNU - C5中水平最高。SNU - C5肿瘤中Glut - 3 mRNA水平也升高,但SNU - C2A和SNU - C4中未升高。不同肿瘤中己糖激酶的酶活性没有差异。
在结肠癌裸鼠模型中,葡萄糖转运蛋白,尤其是Glut - 1,负责[18F]FDG的摄取,而非己糖激酶活性。癌细胞质膜上葡萄糖转运蛋白数量的增加归因于葡萄糖转运蛋白基因转录本水平的升高,这可能是[18F]FDG摄取增加的原因,至少在结肠癌肿瘤中如此。